Opportunistic autoimmunity secondary to cancer immunotherapy (OASI): An emerging challenge.
Kostine M, Chiche L, Lazaro E, Halfon P, Charpin C, Arniaud D, Retornaz F, Blanco P, Jourde-Chiche N, Richez C, Stavris C.
Kostine M, et al. Among authors: retornaz f.
Rev Med Interne. 2017 Aug;38(8):513-525. doi: 10.1016/j.revmed.2017.01.004. Epub 2017 Feb 15.
Rev Med Interne. 2017.
PMID: 28214182
Review.